0000950170-24-001195.txt : 20240103 0000950170-24-001195.hdr.sgml : 20240103 20240103173050 ACCESSION NUMBER: 0000950170-24-001195 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hogue Dale Curtis Jr. CENTRAL INDEX KEY: 0002006649 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33038 FILM NUMBER: 24508338 MAIL ADDRESS: STREET 1: C/O ALAUNOS THERAPEUTICS, INC. STREET 2: 2617 BISSONNET ST, SUITE 225 CITY: HOUSTON STATE: TX ZIP: 77005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alaunos Therapeutics, Inc. CENTRAL INDEX KEY: 0001107421 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841475642 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2617 BISSONNET ST STREET 2: SUITE 225 CITY: HOUSTON STATE: TX ZIP: 77005 BUSINESS PHONE: (346) 355-4099 MAIL ADDRESS: STREET 1: 2617 BISSONNET ST STREET 2: SUITE 225 CITY: HOUSTON STATE: TX ZIP: 77005 FORMER COMPANY: FORMER CONFORMED NAME: ZIOPHARM ONCOLOGY INC DATE OF NAME CHANGE: 20050919 FORMER COMPANY: FORMER CONFORMED NAME: EASYWEB INC DATE OF NAME CHANGE: 20010213 4 1 ownership.xml 4 X0508 4 2023-12-29 0001107421 Alaunos Therapeutics, Inc. TCRT 0002006649 Hogue Dale Curtis Jr. C/O ALAUNOS THERAPEUTICS, INC. 2617 BISSONNET ST, SUITE 225 HOUSTON TX 770005 true false false false false Employee Stock Option (right to buy) 0.071 2023-12-29 4 A false 150000 0.00 A 2033-12-28 Common Stock 150000 150000 D Employee Stock Option (right to buy) 0.071 2023-12-29 4 A false 41667 0.00 A 2033-12-28 Common Stock 41667 41667 D One-thirty sixth of the shares underlying the option vest in equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date. In five equal monthly installments measured from December 29, 2023, with the first vesting occurring on January 29, 2024, subject to the Reporting Person's continued service through each such date. /s/ Michael Wong, By PoA from Dale Curtis Hogue, Jr. 2024-01-03